JPS62161798A - 3 alpha, 7 beta-dihydroxy-12-ketocholanic acid and its production - Google Patents
3 alpha, 7 beta-dihydroxy-12-ketocholanic acid and its productionInfo
- Publication number
- JPS62161798A JPS62161798A JP61308927A JP30892786A JPS62161798A JP S62161798 A JPS62161798 A JP S62161798A JP 61308927 A JP61308927 A JP 61308927A JP 30892786 A JP30892786 A JP 30892786A JP S62161798 A JPS62161798 A JP S62161798A
- Authority
- JP
- Japan
- Prior art keywords
- acid
- formula
- dihydroxy
- compound
- ketocholanic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229960002997 dehydrocholic acid Drugs 0.000 title claims description 8
- 238000004519 manufacturing process Methods 0.000 title claims description 6
- 150000001875 compounds Chemical class 0.000 claims description 14
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 7
- -1 12-ketocholanic acid compound Chemical class 0.000 claims description 6
- 125000004432 carbon atom Chemical group C* 0.000 claims description 5
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical group OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims description 4
- WQYVRQLZKVEZGA-UHFFFAOYSA-N hypochlorite Chemical compound Cl[O-] WQYVRQLZKVEZGA-UHFFFAOYSA-N 0.000 claims description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 3
- 125000001931 aliphatic group Chemical group 0.000 claims description 3
- 238000009835 boiling Methods 0.000 claims description 3
- 230000032050 esterification Effects 0.000 claims description 3
- 238000005886 esterification reaction Methods 0.000 claims description 3
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims description 3
- RPKLZQLYODPWTM-LVVAJZGHSA-N 5beta-cholanic acid Chemical compound C([C@H]1CC2)CCC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)CC1 RPKLZQLYODPWTM-LVVAJZGHSA-N 0.000 claims description 2
- 239000005711 Benzoic acid Substances 0.000 claims description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 2
- 235000010233 benzoic acid Nutrition 0.000 claims description 2
- 239000004220 glutamic acid Substances 0.000 claims description 2
- 235000013922 glutamic acid Nutrition 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims 3
- 125000002252 acyl group Chemical group 0.000 claims 2
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 235000014113 dietary fatty acids Nutrition 0.000 claims 1
- 229930195729 fatty acid Natural products 0.000 claims 1
- 239000000194 fatty acid Substances 0.000 claims 1
- 150000004665 fatty acids Chemical class 0.000 claims 1
- 239000002184 metal Substances 0.000 claims 1
- 230000003647 oxidation Effects 0.000 claims 1
- 238000007254 oxidation reaction Methods 0.000 claims 1
- 239000001384 succinic acid Substances 0.000 claims 1
- 235000011044 succinic acid Nutrition 0.000 claims 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 33
- 239000000203 mixture Substances 0.000 description 17
- 239000002253 acid Substances 0.000 description 16
- RUDATBOHQWOJDD-UHFFFAOYSA-N (3beta,5beta,7alpha)-3,7-Dihydroxycholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)CC2 RUDATBOHQWOJDD-UHFFFAOYSA-N 0.000 description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- 239000000047 product Substances 0.000 description 13
- 238000000034 method Methods 0.000 description 11
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 10
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 10
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 9
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 9
- 239000012535 impurity Substances 0.000 description 9
- RUDATBOHQWOJDD-UZVSRGJWSA-N ursodeoxycholic acid Chemical compound C([C@H]1C[C@@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)CC1 RUDATBOHQWOJDD-UZVSRGJWSA-N 0.000 description 9
- 229960001661 ursodiol Drugs 0.000 description 9
- BHQCQFFYRZLCQQ-UHFFFAOYSA-N (3alpha,5alpha,7alpha,12alpha)-3,7,12-trihydroxy-cholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 BHQCQFFYRZLCQQ-UHFFFAOYSA-N 0.000 description 8
- 239000004380 Cholic acid Substances 0.000 description 8
- 229960002471 cholic acid Drugs 0.000 description 8
- 235000019416 cholic acid Nutrition 0.000 description 8
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 229960001091 chenodeoxycholic acid Drugs 0.000 description 6
- RUDATBOHQWOJDD-BSWAIDMHSA-N chenodeoxycholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)CC1 RUDATBOHQWOJDD-BSWAIDMHSA-N 0.000 description 6
- 239000000243 solution Substances 0.000 description 5
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 4
- FFUAGWLWBBFQJT-UHFFFAOYSA-N hexamethyldisilazane Chemical compound C[Si](C)(C)N[Si](C)(C)C FFUAGWLWBBFQJT-UHFFFAOYSA-N 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- 239000012074 organic phase Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- AYNUEFSRHKFCNX-DOASKDFYSA-N (4s)-4-[(8r,9s,10s,13s,14s,17r)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2,2,3-trihydroxypentanoic acid Chemical compound C1CC2CCCC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@@H](C(O)C(O)(O)C(O)=O)C)[C@@]1(C)CC2 AYNUEFSRHKFCNX-DOASKDFYSA-N 0.000 description 2
- MASDFXZJIDNRTR-UHFFFAOYSA-N 1,3-bis(trimethylsilyl)urea Chemical compound C[Si](C)(C)NC(=O)N[Si](C)(C)C MASDFXZJIDNRTR-UHFFFAOYSA-N 0.000 description 2
- OHXPGWPVLFPUSM-KLRNGDHRSA-N 3,7,12-trioxo-5beta-cholanic acid Chemical compound C1CC(=O)C[C@H]2CC(=O)[C@H]3[C@@H]4CC[C@H]([C@@H](CCC(O)=O)C)[C@@]4(C)C(=O)C[C@@H]3[C@]21C OHXPGWPVLFPUSM-KLRNGDHRSA-N 0.000 description 2
- 239000005708 Sodium hypochlorite Substances 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000007127 saponification reaction Methods 0.000 description 2
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 description 1
- DXOCDBGWDZAYRQ-DVTFWNRPSA-N (4r)-4-[(3r,8r,9s,10s,13r,14s,17r)-3-hydroxy-10,13-dimethyl-7-oxo-1,2,3,4,5,6,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]pentanoic acid Chemical compound C1C[C@@H](O)CC2CC(=O)[C@H]3[C@@H]4CC[C@H]([C@@H](CCC(O)=O)C)[C@@]4(C)CC[C@@H]3[C@]21C DXOCDBGWDZAYRQ-DVTFWNRPSA-N 0.000 description 1
- NEEIOMGUTSQVRZ-WNOQBHAASA-N (4r)-4-[(8r,9s,10s,13r,14s,17r)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2,2-dihydroxypentanoic acid Chemical compound C1CC2CCCC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@@H](CC(O)(O)C(O)=O)C)[C@@]1(C)CC2 NEEIOMGUTSQVRZ-WNOQBHAASA-N 0.000 description 1
- FANVOYSSKZUTGI-NWIAYINOSA-N (8S,9S,10R,13S,14S,17R)-16,16-dihydroxy-13-methyl-7-oxo-17-[(2R)-pentan-2-yl]-2,3,4,5,6,8,9,11,12,14,15,17-dodecahydro-1H-cyclopenta[a]phenanthrene-10-carboxylic acid Chemical compound C1CCCC2CC(=O)[C@H]3[C@@H]4CC(O)(O)[C@H]([C@H](C)CCC)[C@@]4(C)CC[C@@H]3[C@]21C(O)=O FANVOYSSKZUTGI-NWIAYINOSA-N 0.000 description 1
- NDVMCQUOSYOQMZ-UHFFFAOYSA-N 2,2-bis(trimethylsilyl)acetamide Chemical compound C[Si](C)(C)C(C(N)=O)[Si](C)(C)C NDVMCQUOSYOQMZ-UHFFFAOYSA-N 0.000 description 1
- FALRKNHUBBKYCC-UHFFFAOYSA-N 2-(chloromethyl)pyridine-3-carbonitrile Chemical compound ClCC1=NC=CC=C1C#N FALRKNHUBBKYCC-UHFFFAOYSA-N 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- ODINCKMPIJJUCX-UHFFFAOYSA-N Calcium oxide Chemical group [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 1
- 229930194542 Keto Natural products 0.000 description 1
- NBEBETLZMREUCW-ZCVWDVOASA-N OC1([C@@H]([C@]2(C(C[C@@H]3[C@]4(CCCCC4CC[C@H]3[C@@H]2C1)C(=O)O)=O)C)[C@H](C)CCC)O Chemical compound OC1([C@@H]([C@]2(C(C[C@@H]3[C@]4(CCCCC4CC[C@H]3[C@@H]2C1)C(=O)O)=O)C)[C@H](C)CCC)O NBEBETLZMREUCW-ZCVWDVOASA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 150000001558 benzoic acid derivatives Chemical class 0.000 description 1
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical class O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- WBZKQQHYRPRKNJ-UHFFFAOYSA-L disulfite Chemical compound [O-]S(=O)S([O-])(=O)=O WBZKQQHYRPRKNJ-UHFFFAOYSA-L 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 208000001130 gallstones Diseases 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 1
- QWPPOHNGKGFGJK-UHFFFAOYSA-N hypochlorous acid Chemical compound ClO QWPPOHNGKGFGJK-UHFFFAOYSA-N 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 229940014800 succinic anhydride Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- 239000005051 trimethylchlorosilane Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
- C07J9/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
(57)【要約】本公報は電子出願前の出願データであるた
め要約のデータは記録されません。(57) [Summary] This bulletin contains application data before electronic filing, so abstract data is not recorded.
Description
【発明の詳細な説明】
本発明は3−アルファー7−ペータージヒドロキシー1
2−ケトコラン酸系化合物及びその製造方法に関する。DETAILED DESCRIPTION OF THE INVENTION The present invention provides 3-alpha-7-peter dihydroxy-1
The present invention relates to a 2-ketocholanic acid compound and a method for producing the same.
3−アルファー7−ペータージヒドロキシー12−ケト
コラン酸を還元して得られるウルソデオキシコール酸(
3−アルファー7−ベータージヒドロキシコラン酸)は
1人の治療上非常に重要な製品として知られておシ、胆
石の可溶化剤として、血中のコレステロールパーセンテ
ージの低下のため、血糖の低下のため、利尿剤として、
及び脂質代謝の促進剤として利用されている。Ursodeoxycholic acid (obtained by reducing 3-alpha-7-petadihydroxy-12-ketocholanic acid)
3-alpha-7-beta dihydroxycholanic acid) is known as a product of great therapeutic importance, as a gallstone solubilizer, for lowering the percentage of cholesterol in the blood, for lowering blood sugar. , as a diuretic,
It is also used as a promoter of lipid metabolism.
現在用いられているウルソデオキシコール酸の製造方法
は本質的に同一の反応式で表わされ、即ちケノデオキシ
コール酸囚をして3α−ヒドロキシ−7−ケトコラン酸
(B)とし、これを水素添加してウルソデオキシコール
酸(C’)とするものである。The currently used method for producing ursodeoxycholic acid is expressed by essentially the same reaction formula, that is, chenodeoxycholic acid is converted into 3α-hydroxy-7-ketocholanic acid (B), which is then hydrogenated. and ursodeoxycholic acid (C').
以上の一連の反応からなる公知の工程には次の欠点があ
る。化合物Bの還元によシ化合物CB。The known process consisting of the series of reactions described above has the following drawbacks. Compound CB is obtained by reduction of compound B.
係と化合物ムすなわちケノデオキシコール酸2゜係とか
らなる混合物が常に得られ、これからケノデオキシコー
ル酸を除去することは困難であるということである。A mixture is always obtained consisting of chenodeoxycholic acid and the compound chenodeoxycholic acid, from which it is difficult to remove chenodeoxycholic acid.
生成物AとBの混合物を分離するための方法として現在
まで提示されているものは全て工業的にコスト高であシ
また効率に限界がある。All methods proposed to date for separating mixtures of products A and B are industrially expensive and have limited efficiency.
本発明の対象は、更に精製工程t−要することなく、特
にケノデオキシコール酸に汚染されていない製薬用に七
のま\適する高純度のウルソデオキシコール酸の製造に
有用な新規化合物とその製造工程である。The subject of the present invention is a novel compound and a process for its production which are useful for the production of highly pure ursodeoxycholic acid which is suitable for pharmaceutical use without any further purification steps and in particular is not contaminated with chenodeoxycholic acid. be.
新規化合物はコール酸全出発物質とする新規な一連の反
応によって製造される。The new compounds are prepared by a novel series of reactions starting entirely with cholic acid.
この新規方法は本質的に以下の工程からなる。This new method essentially consists of the following steps.
1、 コール酸すなわち3α、7α、12α−トリヒド
ロキシコラン酸(I)の3α、12α、ジヒドロキシ7
−ケトコラン酸(If)への既知の方法(J、 A;
C,S、 7 1 、3935、1 9 4 9 −
J、 A、 C,S、 72.5530.19
50 )による選択的酸化コール酸から酸(II)を調
製するために必要な工程は商業的に広く利用されておシ
、既述した通シの公知の方法によシ行なわれる。1. 3α, 12α, dihydroxy 7 of cholic acid, i.e. 3α, 7α, 12α-trihydroxycholanic acid (I)
- Known methods to ketocholanic acid (If) (J, A;
C, S, 7 1 , 3935, 1 9 4 9 -
J, A, C, S, 72.5530.19
The steps necessary to prepare acid (II) from selectively oxidized cholic acid according to 50) are widely used commercially and are carried out by the commonly known methods described above.
2、酸(■)の水溶液を1−4Cアルコール中でアルカ
リ金属で処理することによる酸(II)の3α、7β、
12α−トリヒドロキシコラン酸(III)への還元
実際上本反応では、酸(III)は、7α異性体すなわ
ちコール酸(1)に対して10〜15%の限定された量
で形成される。2. 3α, 7β, of acid (II) by treating an aqueous solution of acid (■) with an alkali metal in 1-4C alcohol
Reduction to 12α-trihydroxycholanic acid (III) In practice in this reaction, acid (III) is formed in a limited amount of 10-15% relative to the 7α isomer, ie cholic acid (1).
3α、7β、12αトリヒドロキシコラン酸(4)は、
適当な溶媒から結晶化することによシ、又は3.7.1
2.24の一部又は全部をエステル化し、適当な溶媒か
ら結晶化することによシ得た該エステルを精製すること
によって純粋な状態で得ることができる。酸(III)
は、アルカリケン化によって得られた純粋エステルから
得られる。3α, 7β, 12α trihydroxycholanic acid (4) is
by crystallization from a suitable solvent, or 3.7.1
It can be obtained in a pure state by esterifying part or all of 2.24 and purifying the ester obtained by crystallization from a suitable solvent. Acid (III)
is obtained from pure ester obtained by alkaline saponification.
しかし、本発明のためには、純粋な酸(I[)を得る必
要はない。もし、3.7の位置が酸で、24の位置が1
−40アルコールで、適切にエステル化されていれば、
得られたままの状態すなわちコール酸を不純物として含
む状態のま\で次の段階で使うことができる。必要な場
合、これらのエステル化は、通常のエステル化法により
連続的に行なうことができる。However, for the present invention it is not necessary to obtain pure acid (I[). If position 3.7 is an acid and position 24 is 1
-40 alcohol, if properly esterified,
It can be used in the next step in its obtained state, that is, in its state containing cholic acid as an impurity. If necessary, these esterifications can be carried out continuously by conventional esterification methods.
生成物の式 は新規な化合物である。product formula is a new compound.
〔Rは、水素又は、好ましくは炭素数2〜6の脂肪族酸
基若しくは単−又は置換された安息香酸、コハク酸、若
しくはグルタミン酸よシなるグループから選んだ酸基で
あシ、R′は水素又は炭素数1〜4の脂肪族基〕。[R is hydrogen or preferably an aliphatic acid group having 2 to 6 carbon atoms or an acid group selected from the group consisting of mono- or substituted benzoic acid, succinic acid, or glutamic acid; R' is hydrogen or an aliphatic group having 1 to 4 carbon atoms].
3.3と7の位置がエステル化されている3α。3.3α is esterified at positions 3 and 7.
7β、12α−トリヒトaキシ−5β−コラン酸を、次
式に従い酢酸中で次亜塩素酸アルカリ塩によって3α、
7β−ジヒドロキシ−12ケト−5βコラン酸に酸化す
る。7β,12α-trihydroxy-5β-cholanic acid was converted to 3α,
Oxidizes to 7β-dihydroxy-12keto-5β-cholanic acid.
弼 式中R及びR′は前述の通シである。弼 In the formula, R and R' are as defined above.
過剰の次亜塩素酸は重亜硫酸塩で破壊される。Excess hypochlorous acid is destroyed with bisulfite.
遊離3α、7β−ジヒドロキシ12ケト−5β−コラン
酸は、強アルカリの希釈液でケン化し次いで酸性にする
ことによって得られる。Free 3α,7β-dihydroxy 12keto-5β-cholanic acid is obtained by saponification with a strong alkaline dilute solution followed by acidification.
このようにして得られる遊離酸(IV)は、主に3α、
7α−ジヒドロキシ−12ケト−5β−コラン酸及び未
反応の3α−7β−12α−トリヒドロキシコラン酸か
らなる不純物を含む。式(IV)の生成物は新規化合物
でおる。The free acid (IV) obtained in this way is mainly 3α,
Contains impurities consisting of 7α-dihydroxy-12keto-5β-cholanic acid and unreacted 3α-7β-12α-trihydroxycholanic acid. The product of formula (IV) is a new compound.
4.3α、7β−ジヒドロキシ−12ケト−5βコラン
酸を、温度30℃〜100℃マ有機溶媒溶液中で、ビス
−トリメチルシリルウレア、ヘキサメチルジシラザン又
はビス−トリメチルシリルアセトアミドのようなシラン
化剤で処理することによシ、そのトリス−トリメチルシ
リル誘導体全調製し精製する。4.3α,7β-dihydroxy-12keto-5β-cholanic acid is treated with a silanizing agent such as bis-trimethylsilylurea, hexamethyldisilazane or bis-trimethylsilylacetamide in an organic solvent solution at a temperature of 30°C to 100°C. By processing, the entire tris-trimethylsilyl derivative is prepared and purified.
驚いたことに、化合物(V)は有機溶媒にきわめてわず
かしか溶けない。それに反し、不純物及び特に3α、7
α−ジヒドロキシ−12ケト−5β−フラン酸は同じ溶
媒に非常によく浴ける。Surprisingly, compound (V) is only very slightly soluble in organic solvents. On the contrary, impurities and especially 3α, 7
α-dihydroxy-12keto-5β-furanic acid bathes very well in the same solvent.
式(V)の化合物もまた新規な化合物である。The compound of formula (V) is also a new compound.
5、次式に沿って、水溶液又は有機溶媒中で好ましくは
塩酸の酸加水分解によってトリメチルシリル群を、除去
する。5. The trimethylsilyl group is removed by acid hydrolysis, preferably with hydrochloric acid, in an aqueous solution or an organic solvent according to the following formula:
(ロ)
このようにして本発明にがかる3α、7β−ジヒドロキ
シ−12−ケトコラン酸及びその誘導体が得られる。二
つのヒトミキシ基及びカルがキシル基における各種エス
テルは常法によシ得ることができる。(b) In this way, 3α,7β-dihydroxy-12-ketocholanic acid and its derivatives according to the present invention are obtained. Various esters of two human mixi groups and cal-xyl groups can be obtained by conventional methods.
6、 &で得られたケト化合物は以下のように還元さ
れてウルソデオキシコール酸となる。ウルツ・キッシュ
チー法に従い、アルカリ基及びトリエチレングリコール
の存在下でヒドラジン水化物と共に200℃まで加熱す
ることによシ3α、7β−ジヒドロキシ−12−ケト−
5βコラン酸をウルソデオキシコール酸に還元する。6. The keto compound obtained in & is reduced to ursodeoxycholic acid as follows. 3α,7β-dihydroxy-12-keto- by heating to 200°C with hydrazine hydrate in the presence of an alkali group and triethylene glycol according to the Wurz-Kishchi method.
5β-cholanic acid is reduced to ursodeoxycholic acid.
工程(5)と(6)は逆にしてもよい。ウルツ・キラシ
ャー還元はトリス−トリメチルシラン誘導体について行
なうことができ、トリメチルシリル群は。Steps (5) and (6) may be reversed. Wurz-Killascher reduction can be carried out on tris-trimethylsilane derivatives, the trimethylsilyl group.
既に還元された化合物すなわち高純度ウルソデオキシコ
ール酸のトリス−トリメチルシリル誘導体から除去する
ことができるからである。This is because it can be removed from an already reduced compound, ie, a tris-trimethylsilyl derivative of high purity ursodeoxycholic acid.
二つの工程を交換しても本質的に同じ結果が得られる。Essentially the same result can be obtained by interchanging the two steps.
本発明に従りた新規な工程は、広く利用可能な出発物質
を使っているという長所、また。The novel process according to the invention also has the advantage of using widely available starting materials.
簡単で選択率の高い反応を利用した数少ない工程でウル
ソデオキシコール酸に変え得るという長所を有している
。しかも、複雑でコストの高齢精製工程なしに、薬学的
純反の製品を直接導ひくことができるという長所を有す
る。It has the advantage that it can be converted to ursodeoxycholic acid in a few steps using a simple reaction with high selectivity. In addition, it has the advantage of directly producing pharmaceutically pure products without complicated and expensive purification processes.
本発明の工程をよシ簡単に再現し得るよう以下にいくつ
かの実施例’t6げる。しかし、それらは発明の範囲を
限定するものではない。Several examples are provided below so that the process of the present invention can be more easily reproduced. However, they do not limit the scope of the invention.
実施例1
コール酸(1) k選択的に酸化して(J、 A、 C
,S・71、3955/1949 :J、A、C,S、
72.5530/1950に従い)得られた3α、1
2α、ジヒドロキシ−7−ケトコラン酸、100Iit
−二級プチルアルコール2000−に溶解する。溶液を
沸騰するまで加熱し、100IIのナトリウム金属を添
加する。還流下に、沸騰を2時間続ける。ブチルアルコ
ールは蒸留され、同時に同量の水を加える。ブチルアル
コールが全て除去された時、混合物を冷却し、20%塩
酸で酸性にする。得られた沈澱物を口過し、水洗し乾燥
する。HPLC分析では3α、7β、12α−トリヒド
ロキシ−コラン酸88.9%、!−ル酸9.2%からな
る乾燥非晶質生成物95IIが得られた。Example 1 Cholic acid (1) k selectively oxidized (J, A, C
, S. 71, 3955/1949: J, A, C, S.
72.5530/1950) obtained 3α, 1
2α, dihydroxy-7-ketocholanic acid, 100Iit
-Dissolve in secondary butyl alcohol 2000-. Heat the solution to boiling and add 100 II of sodium metal. Boiling is continued for 2 hours under reflux. Butyl alcohol is distilled and at the same time an equal amount of water is added. When all butyl alcohol has been removed, the mixture is cooled and acidified with 20% hydrochloric acid. The resulting precipitate is passed through the mouth, washed with water and dried. HPLC analysis shows 88.9% of 3α, 7β, 12α-trihydroxy-cholanic acid! A dry amorphous product 95II was obtained, consisting of 9.2% of -alic acid.
酸滴定 99.1%
〔α〕D 謔71.2°(C−1% ジオキサン中)前
工程で得た。;−ル酸な不純物として含む、3α、7β
、12α−トリヒドロキシコラン酸50Iiに、ベンゼ
ン200−、ピリジン50m、無水酢酸50dを加える
。20℃〜25℃で45時間混合物を反応させ、次いで
50−の水を攪拌しながら加え、数分後水200mと3
7%塩酸60−の混合物を加える。液相を廃棄し、有機
相を脱水し乾燥状態にする。Acid titration 99.1% [α]D 71.2° (C-1% in dioxane) obtained in the previous step. ;-3α, 7β included as acidic impurities
, 200 m of benzene, 50 m of pyridine, and 50 d of acetic anhydride are added to 50 Ii of 12α-trihydroxycholanic acid. The mixture was allowed to react at 20°C to 25°C for 45 hours, then 50 m of water was added with stirring, and after a few minutes 200 m of water and 3
Add a mixture of 60-7% hydrochloric acid. The liquid phase is discarded and the organic phase is dehydrated to dryness.
3,7ジ酢酸エステルを含む残留物を500−の酢酸エ
チルにとシ、それに80%酢酸30tntと15係次亜
塩素酸ナトリウムを加える。The residue containing 3,7 diacetate was dissolved in 500% ethyl acetate, and 30 tons of 80% acetic acid and 15% sodium hypochlorite were added thereto.
混合物′f、1時間攪拌し、余剰次亜塩素酸塩をメタ重
亜硫酸塩で破壊し、酢酸エチルは500−の水で水洗さ
れる。The mixture 'f is stirred for 1 hour, the excess hypochlorite is destroyed with metabisulfite, and the ethyl acetate is washed with 500 ml of water.
無機相を脱水し乾燥状態にし、10係NaOH200m
gとともに5時間沸騰する。Dehydrate the inorganic phase, dry it, and add 200 m of 10% NaOH.
Boil for 5 hours with g.
それをHCtで酸性にし、酢酸エチルで抽出する。It is acidified with HCt and extracted with ethyl acetate.
脱水し乾燥状態にした有機相から451の残留物が得ら
れ、HPLC分析では
であった。A residue of 451 was obtained from the dehydrated and dried organic phase and was analyzed by HPLC.
前工程で得られた不純物生成物50gをN、N−ジメチ
ルホルムアミド500−中に溶解する。50 g of the impure product obtained in the previous step are dissolved in 500 g of N,N-dimethylformamide.
ビス−トリメチルシリルウレア50gを加え。Add 50 g of bis-trimethylsilyl urea.
混合物を100℃に加熱し、その温度で1時間攪拌しそ
の後冷却する。The mixture is heated to 100° C., stirred at that temperature for 1 hour and then cooled.
3α、7β−ビストリメチルシリルエーテル−24トリ
メチルシリルエステルが晶析し、口過し、N、N−ジメ
チルホルムアミド50mで洗う。3α,7β-bistrimethylsilyl ether-24 trimethylsilyl ester is crystallized, filtered through the mouth and washed with 50ml of N,N-dimethylformamide.
それを70℃真空中で乾燥する。It is dried at 70°C in vacuum.
得られた60.9の生成物の特性は
分子量=623.13
融 点=155°〜157℃
前工程で得た、トリス−トリメチルシリル5゜1をトリ
エチレングリコール500m/、中に俗解し、80%ヒ
ドロジン水和物5o−及びKOH501を加え、混合物
を約200℃に加熱する。The properties of the obtained product of 60.9 are as follows: Molecular weight = 623.13 Melting point = 155° to 157°C % hydrozine hydrate 5o- and KOH 501 are added and the mixture is heated to about 200<0>C.
反応が終わったら冷却し、水2000−で希釈しHCl
で酸性にする。After the reaction is complete, cool it down, dilute it with 2000ml of water, and add HCl.
Make it acidic.
生成物を口過し、水洗し酢酸エチルから結晶化させる。The product is filtered, washed with water and crystallized from ethyl acetate.
次の特性をもつクルソデオキシコール酸2511が得ら
れた。Cursodeoxycholic acid 2511 was obtained with the following properties.
融 点=202〜205℃
〔α] =+60°±2(C=1% ジオキサン中)
ケノデオキシコール酸不純物 ≦1%
他の不純物計 ≦0.3係実施例2
100#の金属カリウムを、2000−のn−ブチルア
ルコールに溶解された100#の3α、12α−ノヒド
ロキシー7−ケトコラン酸に沸騰条件下で添加し、混合
物を還流下で2時間加熱する。Melting point = 202-205°C [α] = +60°±2 (C = 1% in dioxane)
Chenodeoxycholic acid impurity ≦1% Other impurities ≦0.3 Example 2 100 # of metallic potassium was boiled into 100 # of 3α, 12 α-nohydroxy-7-ketocholanic acid dissolved in 2000 # of n-butyl alcohol. and the mixture is heated under reflux for 2 hours.
その後、水を供給しながら全てのn−ブチルアルコール
を留去す仝。蒸留が終了した後、混合物を20%HC1
で酸性化し、沈澱固形物を戸別する。Thereafter, all the n-butyl alcohol was distilled off while water was being supplied. After the distillation is finished, the mixture is diluted with 20% HCl
Acidify with water and separate the precipitated solids.
固形物(95,9)’(i−HPLC分析にかけると、
9゜係の3α、7β、12α−トリヒドロキシコラン酸
及び10係のコール酸からなることが分る。混合物の特
性は実施例1の場合と同様である。Solid (95,9)' (when subjected to i-HPLC analysis,
It can be seen that it consists of 3α, 7β, 12α-trihydroxycholanic acid with a 9° chain and cholic acid with a 10 chain. The properties of the mixture are similar to those in Example 1.
この段階で得られた3α、7β、12α−トリヒドロキ
シコラン酸及びコール酸の混合物100Iを150−の
ピリジンに浴解し、100gのこはく酸無水物を添加し
、混合物を80℃で5時間加熱する。100 I of the mixture of 3α, 7β, 12α-trihydroxycholanic acid and cholic acid obtained in this step was dissolved in 150-pyridine, 100 g of succinic anhydride was added and the mixture was heated at 80° C. for 5 hours. do.
0℃に冷却し、100ゴの水を加える。2時間攪拌を続
ける。1000−の酢酸エチルを添加し、HCtで−を
3〜3.5に調節する。水性相を分離する。Cool to 0°C and add 100 g of water. Continue stirring for 2 hours. Add 1000 - of ethyl acetate and adjust - to 3-3.5 with HCt. Separate the aqueous phase.
この段階で得られた有機済液に50−の酢酸及び50−
のlO%KBr水浴液全添加し、次いで温度を20℃に
調節する。この温度を保ちながら、150−の15%次
亜塩素酸ナトリウム浴i’を添加する。The organic liquid obtained in this step contains 50-acetic acid and 50-
of 10% KBr water bath solution is added and the temperature is then adjusted to 20°C. While maintaining this temperature, a 150-15% sodium hypochlorite bath i' is added.
混合物を30分間攪拌し、生成物を戸別し。The mixture was stirred for 30 minutes and the product was distributed door to door.
200W1tの酢酸エチルで洗浄し、so’cのオーブ
ン中で乾燥させる。Wash with 200W1t ethyl acetate and dry in a SO'C oven.
乾燥生成物を10001ntの10%NaOHとともに
2時間沸騰させ、次に冷却し、1000−の酢酸エチル
を添加し、混合物を204 HO2で酸性化する。The dry product is boiled with 10001 nt of 10% NaOH for 2 hours, then cooled, 1000 ml of ethyl acetate is added and the mixture is acidified with 204 HO2.
有機相を分離し、体積的300−迄蒸発させる。The organic phase is separated and evaporated to 300 ml by volume.
0℃に冷却し、濾過する。Cool to 0°C and filter.
生成物を100−の酢酸エチルで洗浄し、80℃のオー
ブン中で乾燥させる。The product is washed with 100% ethyl acetate and dried in an oven at 80°C.
70yの純粋でない3α、7β−ジヒドロキシ−12−
ケトコラン酸が得られる。70y impure 3α,7β-dihydroxy-12-
Ketocholanic acid is obtained.
この段階で得られた純粋でない3α、7β−ジヒドロキ
シ−12−ケトプラン酸100Nに、100tdのアセ
トニトリル、700−のヘキサメチルジシラザン及び3
00−のトリメチルクロロシランを添加する。還流下で
1時間加熱し、次いで冷却する。3α、7β−ビス−ト
リメチルシリルエーテル−24−) +7メチルシリル
エステルが晶出し、これを戸別し、アセトニトリルで洗
浄し、真空下60℃で乾燥させる。To 100 N of impure 3α,7β-dihydroxy-12-ketopranic acid obtained in this step, 100 td of acetonitrile, 700- of hexamethyldisilazane and 3
Add 00-trimethylchlorosilane. Heat under reflux for 1 hour, then cool. 3α,7β-bis-trimethylsilyl ether-24-) +7 methylsilyl ester crystallizes out, which is separated, washed with acetonitrile and dried under vacuum at 60°C.
かくして得られたトリス−トリメチルシリル誘導体50
.9を50℃の温度で10分間で500mの酢酸エチル
及び100−の10%HC1中に攪拌しながら溶解する
。有機相を分離し、100−の水で洗浄する。濃縮する
と、極めて純粋な3α、7β−ジヒドロキシ−12−ケ
ト−5β−フラン酸が晶出し、これを濾過し、酢酸エチ
ルで洗浄し、80℃のオープン中で乾燥させる。The thus obtained tris-trimethylsilyl derivative 50
.. 9 is dissolved with stirring in 500 m of ethyl acetate and 100 m of 10% HCl for 10 minutes at a temperature of 50°C. The organic phase is separated and washed with 100 ml of water. Upon concentration, very pure 3α,7β-dihydroxy-12-keto-5β-furanic acid crystallizes out, which is filtered, washed with ethyl acetate and dried in the open at 80°C.
特性:
・分子量−406,5
・融 点ね190℃
・ 〔α] =+108°±3(C−1%、ジオキ
サン中)・クロマトグラフィーによシ測定された不純物
総量≦0.5%
5011の純粋な3α、7β−ジヒドaキシ−12−ケ
トコラン酸を500−のトリエチレングリコール、50
−の80%Lドラジン水和物及び501 (D KOH
中に溶解し、溶液を200℃で1時間加熱する。Characteristics: ・Molecular weight -406.5 ・Melting point 190℃ ・[α] = +108°±3 (C-1%, in dioxane) ・Total amount of impurities measured by chromatography ≦0.5% of 5011 Pure 3α,7β-dihydro-axy-12-ketocholanic acid was dissolved in 500-triethylene glycol, 50%
-80% of L dorazine hydrate and 501 (D KOH
and heat the solution at 200° C. for 1 hour.
反応終了後、混合物を冷却し、200−の水で希釈し、
HClで酸性化する。生成物を濾過によシ分離し、酢
酸エチルから晶出せしめる。After the reaction is complete, the mixture is cooled and diluted with 200-ml water.
Acidify with HCl. The product is separated by filtration and crystallized from ethyl acetate.
4511の極めて純粋なウルソデオキシコール酸が得ら
れ、これは次の特性をもつ:
・融 点な202〜205℃
・〔α)、 −+60’±2 (C−1%、ジオキサ
ン中)・不純物総量≦l係
実施例3
トリス−トリメチルシリル誘導体の調製を含む工程を除
き実施例1と同様に行なった。N−N−ジメチルホルム
アミド500−に溶解した不純物を含む、3α、7β−
ジヒドロキシ−12−ケトコラン酸5011にビス−ト
リメチルシリル−アセトアミド50−を加える。混合物
を100℃に加熱し、攪拌しながらその温度に1時間保
持し、次いで冷却する。100℃で1時間口過析出物を
、ビス−トリメチルシリル−アセトアミrlo−の存在
下でN、N−ジメチルホルムアミドから再結晶させる。4511 extremely pure ursodeoxycholic acid is obtained, which has the following properties: Melting point 202-205°C [α), -+60'±2 (C-1% in dioxane) Impurities Total amount≦l Example 3 The same procedure as Example 1 was carried out except for the step involving the preparation of the tris-trimethylsilyl derivative. 3α, 7β- containing impurities dissolved in N-N-dimethylformamide 500-
Bis-trimethylsilyl-acetamide 50- is added to dihydroxy-12-ketocholanic acid 5011. The mixture is heated to 100° C. and held at that temperature for 1 hour with stirring, then cooled. The precipitate obtained after 1 hour at 100 DEG C. is recrystallized from N,N-dimethylformamide in the presence of bis-trimethylsilyl-acetamyl lo-.
それを口過し、水洗し、70℃真空中で乾燥する。It is passed through the mouth, washed with water and dried in vacuum at 70°C.
3α、7β−ジヒドロキシ−12ケトコラン酸のトリス
−トリメチルシリル誘導体61.fが得られた。その特
性は実施例1で述べたのと同様である。Tris-trimethylsilyl derivative of 3α,7β-dihydroxy-12-ketocholanic acid 61. f was obtained. Its characteristics are similar to those described in Example 1.
Claims (2)
芳香族酸基、R′はH、−Si(CH_3)_3又は炭
素数1〜4のアルキル)の3α,7β−ジヒドロキシ−
12−ケトコラン酸系化合物。(1) Formula ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼ (In the formula, R is H, -Si(CH_3)_3 or an aliphatic or aromatic acid group, R' is H, -Si(CH_3)_3 or the number of carbon atoms 3α,7β-dihydroxy- of 1-4 alkyl)
12-ketocholanic acid compound.
から出発し、基本的に以下の工程; (a)化合物(II)が、その炭素数1〜4の脂肪族アル
コール中の溶液をアルカリ性金属で、該アルコールの沸
騰温度で処理することにより 式(III) ▲数式、化学式、表等があります▼ (III) の化合物3−α,7−β,12−α−トリヒドロキシ−
5−β−コラン酸に還元される; (b)式(III)の化合物が3と7の位置で炭素数2〜
6の脂肪酸、安息香酸、コハク酸又はグルタミン酸で、
対応するグループ−OR(Rはアシル基)を得て、エス
テル化される; (c)前工程bのエステル化生成物が酢酸中アルカリ性
ハイポクロライトにより酸化処理に付され、式 ▲数式、化学式、表等があります▼ (IV) (式中Rは前工程bで定義された如きアシル基である。 ) の12−ケト誘導体を得る; からなる式(IV)の3α,7β−ジヒドロキシ−12−
ケトコラン酸系化合物の製造方法。(2) Formula (II) ▲There are mathematical formulas, chemical formulas, tables, etc.▼ Starting from 3-α,12-α-dihydroxy-7-ketocholanic acid of (II), basically the following steps; (a) Compound By treating a solution of (II) in an aliphatic alcohol having 1 to 4 carbon atoms with an alkaline metal at the boiling temperature of the alcohol, formula (III) can be obtained. The compound 3-α,7-β,12-α-trihydroxy-
reduced to 5-β-cholanic acid; (b) the compound of formula (III) has 2 to 7 carbon atoms at the 3 and 7 positions;
6 fatty acids, benzoic acid, succinic acid or glutamic acid,
The corresponding group -OR (R is an acyl group) is obtained and esterified; (c) The esterification product of the previous step b is subjected to oxidation treatment with alkaline hypochlorite in acetic acid to form the formula ▲ mathematical formula, chemical formula , tables etc. ▼ Obtain the 12-keto derivative of (IV) (wherein R is an acyl group as defined in the previous step b); 3α,7β-dihydroxy-12 of formula (IV) consisting of −
A method for producing a ketocholanic acid compound.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT21137A/81 | 1981-04-14 | ||
IT21137/81A IT1137459B (en) | 1981-04-14 | 1981-04-14 | PRODUCTION FOR THE PREPARATION OF HIGH PURITY URSODEOXICOLIC ACID |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2234631A Division JPH03128392A (en) | 1981-04-14 | 1990-09-06 | Method for purification of 3 alpha, 7 beta- dihydroxy-12-keto cholanic acid compound |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS62161798A true JPS62161798A (en) | 1987-07-17 |
JPH0132238B2 JPH0132238B2 (en) | 1989-06-29 |
Family
ID=11177288
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP57061161A Granted JPS57203097A (en) | 1981-04-14 | 1982-04-14 | Manufacture of high purity ulsodeoxycholic acid |
JP61308927A Granted JPS62161798A (en) | 1981-04-14 | 1986-12-26 | 3 alpha, 7 beta-dihydroxy-12-ketocholanic acid and its production |
JP2234631A Granted JPH03128392A (en) | 1981-04-14 | 1990-09-06 | Method for purification of 3 alpha, 7 beta- dihydroxy-12-keto cholanic acid compound |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP57061161A Granted JPS57203097A (en) | 1981-04-14 | 1982-04-14 | Manufacture of high purity ulsodeoxycholic acid |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2234631A Granted JPH03128392A (en) | 1981-04-14 | 1990-09-06 | Method for purification of 3 alpha, 7 beta- dihydroxy-12-keto cholanic acid compound |
Country Status (13)
Country | Link |
---|---|
US (1) | US4379093A (en) |
EP (1) | EP0063106B1 (en) |
JP (3) | JPS57203097A (en) |
AT (1) | ATE15207T1 (en) |
CA (1) | CA1185233A (en) |
DE (1) | DE3265743D1 (en) |
DK (1) | DK164882A (en) |
ES (1) | ES511382A0 (en) |
IE (1) | IE53198B1 (en) |
IT (1) | IT1137459B (en) |
NO (1) | NO162665C (en) |
PT (1) | PT74749B (en) |
YU (1) | YU43074B (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2511007A1 (en) * | 1981-08-07 | 1983-02-11 | Roussel Uclaf | PROCESS FOR THE PREPARATION OF URSODESOXYCHOLIC ACID FROM 3A, 7B, 12A-TRIHYDROXYCHOLANIC ACID AND INTERMEDIATE PRODUCT USED |
IT1150756B (en) * | 1982-04-02 | 1986-12-17 | Zambon Spa | PROCEDURE FOR PREPARING 3ALPHA, 7BETA-DIHYDROXY-5BETA-COLANIC ACID |
IE73449B1 (en) * | 1989-10-17 | 1997-06-04 | Sanofi Sa | Process for the production of chenodeoxycholic |
FR2653128B1 (en) * | 1989-10-17 | 1995-03-17 | Sanofi Sa | PROCESS FOR THE PREPARATION OF CHENODESOXYCHOLIC ACID. |
FR2653127B1 (en) * | 1989-10-17 | 1994-12-09 | Sanofi Sa | PROCESS FOR THE PREPARATION OF 12-OXOCHOLANATES. |
FR2653129B1 (en) * | 1989-10-17 | 1995-03-17 | Sanofi Sa | PROCESS FOR THE PREPARATION OF 7-OXOCHOLANATES. |
JPH04152543A (en) * | 1990-10-16 | 1992-05-26 | Agency Of Ind Science & Technol | Integrated circuit structure body provided with self-inspection function; sorting method of good integrated circuit chip by using it |
NZ245504A (en) * | 1991-12-20 | 1995-08-28 | Hoechst Ag | Bile acid derivatives containing an ethylenically unsaturated grouping |
DE4432708A1 (en) * | 1994-09-14 | 1996-03-21 | Hoechst Ag | Modified bile acids, process for their preparation and their use |
IL139241A0 (en) * | 1998-05-13 | 2001-11-25 | Novo Nordisk As | Meiosis regulating compounds |
CA2440680C (en) | 2001-03-12 | 2010-06-01 | Roberto Pellicciari | Steroids as agonists for fxr |
WO2006007675A1 (en) * | 2004-07-20 | 2006-01-26 | Libbs Farmacêutica Ltda. | Cholic acid and/or its derivatives for the reduction of localized fat in the human body |
KR101881245B1 (en) * | 2012-06-19 | 2018-07-23 | 인터셉트 파마슈티컬즈, 인크. | Preparation, uses and solid forms of obeticholic acid |
CN114195852A (en) * | 2021-12-28 | 2022-03-18 | 中山百灵生物技术股份有限公司 | Preparation method of 3 beta, 7 beta-dihydroxy-5 beta-cholanic acid |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5012434A (en) * | 1973-06-04 | 1975-02-08 | ||
JPS5233638A (en) * | 1975-09-08 | 1977-03-14 | Mitsui Petrochem Ind Ltd | Process for preparation of aromatic alcohols |
JPS5323302A (en) * | 1976-08-18 | 1978-03-03 | Mitsui Petrochem Ind Ltd | Thermal cracking of hydrocarbons |
JPS5536680A (en) * | 1978-09-08 | 1980-03-14 | Jidosha Kiki Co Ltd | Flow control valve |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2446293A1 (en) * | 1978-12-11 | 1980-08-08 | Roussel Uclaf | PROCESS OF PURIFICATION OF CHENODESOXYCHOLIC ACID |
FR2444048B1 (en) * | 1978-12-15 | 1981-08-14 | Roussel Uclaf | |
IT1165252B (en) * | 1979-07-12 | 1987-04-22 | Blasinachim Spa | PURIFICATION PROCEDURE FOR URSODESOXICOLIC ACID THROUGH NEW DERIVATIVES |
-
1981
- 1981-04-14 IT IT21137/81A patent/IT1137459B/en active
- 1981-06-24 US US06/277,005 patent/US4379093A/en not_active Expired - Fee Related
-
1982
- 1982-04-05 DE DE8282830083T patent/DE3265743D1/en not_active Expired
- 1982-04-05 IE IE803/82A patent/IE53198B1/en not_active IP Right Cessation
- 1982-04-05 AT AT82830083T patent/ATE15207T1/en not_active IP Right Cessation
- 1982-04-05 EP EP82830083A patent/EP0063106B1/en not_active Expired
- 1982-04-13 ES ES511382A patent/ES511382A0/en active Granted
- 1982-04-13 NO NO821194A patent/NO162665C/en unknown
- 1982-04-13 CA CA000400880A patent/CA1185233A/en not_active Expired
- 1982-04-13 DK DK164882A patent/DK164882A/en not_active Application Discontinuation
- 1982-04-13 YU YU802/82A patent/YU43074B/en unknown
- 1982-04-14 PT PT74749A patent/PT74749B/en not_active IP Right Cessation
- 1982-04-14 JP JP57061161A patent/JPS57203097A/en active Granted
-
1986
- 1986-12-26 JP JP61308927A patent/JPS62161798A/en active Granted
-
1990
- 1990-09-06 JP JP2234631A patent/JPH03128392A/en active Granted
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5012434A (en) * | 1973-06-04 | 1975-02-08 | ||
JPS5233638A (en) * | 1975-09-08 | 1977-03-14 | Mitsui Petrochem Ind Ltd | Process for preparation of aromatic alcohols |
JPS5323302A (en) * | 1976-08-18 | 1978-03-03 | Mitsui Petrochem Ind Ltd | Thermal cracking of hydrocarbons |
JPS5536680A (en) * | 1978-09-08 | 1980-03-14 | Jidosha Kiki Co Ltd | Flow control valve |
Also Published As
Publication number | Publication date |
---|---|
DK164882A (en) | 1982-10-15 |
IT8121137A0 (en) | 1981-04-14 |
DE3265743D1 (en) | 1985-10-03 |
EP0063106B1 (en) | 1985-08-28 |
NO162665B (en) | 1989-10-23 |
YU43074B (en) | 1989-02-28 |
JPH045680B2 (en) | 1992-02-03 |
IE820803L (en) | 1982-10-14 |
CA1185233A (en) | 1985-04-09 |
JPH03128392A (en) | 1991-05-31 |
JPS57203097A (en) | 1982-12-13 |
ATE15207T1 (en) | 1985-09-15 |
JPH0132238B2 (en) | 1989-06-29 |
US4379093A (en) | 1983-04-05 |
NO162665C (en) | 1990-01-31 |
ES8307835A1 (en) | 1983-09-01 |
PT74749B (en) | 1983-11-08 |
ES511382A0 (en) | 1983-09-01 |
IT1137459B (en) | 1986-09-10 |
PT74749A (en) | 1982-05-01 |
JPS6320439B2 (en) | 1988-04-27 |
IE53198B1 (en) | 1988-08-31 |
NO821194L (en) | 1982-10-15 |
EP0063106A1 (en) | 1982-10-20 |
YU80282A (en) | 1985-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS62161798A (en) | 3 alpha, 7 beta-dihydroxy-12-ketocholanic acid and its production | |
JP2009518456A (en) | Method for purifying chenodeoxycholic acid | |
US3687982A (en) | Separation of mixed diastereoisomers of zearalanol | |
US4104285A (en) | Taurine and glycine derivatives | |
JP5107262B2 (en) | Method for purifying chenodeoxycholic acid | |
US3965131A (en) | Process for the purification of crude chenodeoxycholic acid | |
JPS61100593A (en) | Griseolic acid derivative | |
EP0386538B1 (en) | Process for preparing high purity 3-alpha-7-beta-dihydroxycholanic acid | |
JPS5850240B2 (en) | Production method for new androstane-based diene derivatives | |
JPS6254316B2 (en) | ||
US2705232A (en) | Ternorcholanylthiazoles | |
KR870001937B1 (en) | Process for preparing(3-keto omega 4 or omega 1,4)-7-substituted steroid derivatives | |
JPH07116221B2 (en) | Method for producing ursodeoxycholic acid | |
US3168535A (en) | Preparation of crystalline vitamin d3 and vitamin d3 benzoate | |
US2693476A (en) | Beta-carbonyl carboxylic acid esters of steroids | |
JPS6351156B2 (en) | ||
US2334695A (en) | 17-hydroxy-3-keto-compounds of the cyclopentano polyhydropkenanthrene series and a method for producing the same | |
JP3291987B2 (en) | Purification method of O, S-dimethyl-N-acetylphosphoramidothioate | |
JPS58113202A (en) | Purification of bile acid | |
US2749356A (en) | Method of isolating and purifying keto steroids and new keto steroid compounds | |
US2549947A (en) | Hemi-diethylene glycol adduct of 3, 12-dihydroxy-7-ketocholanic acid and preparationthereof | |
EP0157151B1 (en) | New process for preparing cis-3,3,5-trimethylcyclohexyl-d,l-alpha-(3-pyridinecarboxy)-phenylacetate | |
JPH0359063B2 (en) | ||
JP4121044B2 (en) | Method for producing sialic acid derivative | |
US2587579A (en) | Intermediate compounds in the synthesis of dehydrocorticosterone |